The Muscular Dystrophy Association has put out recommendations for people with neuromuscular diseases regarding COVID-19. Current guidelines for COVID-19 exposure have focused on specific communities related to risk to travelers, the elderly, and those with conditions that affect respiratory health. To inform the neuromuscular community of particular information that is relevant to COVID-19, the MDA has prepared the following information, which expands on the CDC recommendations for the general population. Click the link here to keep up to date on best practices for managing the global spread of SARS-CoV-2.
Muscular Dystrophy News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.